Developer docs
API playgroundTry for free, no card

Search company profiles

OSSTEC

Full company profile

uuid0002cdc

Namestring
OSSTEC
Legal namestring
OSSTEC Ltd
Websiteurl
osstec.uk
Company typeenum
Private
Founded yearint
2021
Descriptiontext

OSSTEC Ltd is a UK-based orthopaedic medical device company incorporated in England and Wales and headquartered at Imperial College London, London, from which it spun out. The company develops 3D-printed knee implants built on a biomimetic cementless fixation platform that the company claims reduces the risk of implant loosening by approximately 50% compared with cemented alternatives and addresses a 35% long-term failure rate in younger, more active patients. Its flagship offering, the ASCENT Cementless Partial Knee System, combines novel 3D-printed articulating surfaces with cementless biologic fixation derived from roughly a decade of research at Imperial College London.

OSSTEC generates revenue through hardware sales of its implants to hospitals and surgical centres via enterprise field sales and direct hospital distribution, with pricing negotiated through hospital procurement. The go-to-market is targeted at orthopaedic surgeons performing partial knee replacement, a procedure it estimates is appropriate for about 50% of knee replacement candidates based on its published content. The company is led by surgeons and engineers, including CTO & Co-Founder Jonathan Jeffers, Founder & CEO Maxwell Munford, and Chair Dominique Kleyn, with clinical endorsement from academic surgeons such as Mr. Alex Liddle (DPhil FRCS(Orth)).

The company remains at an early commercial stage: it employs 1-10 people, has raised a £2.5 million seed round in April 2025 alongside earlier seed capital, and is actively pursuing FDA regulatory clearance for the ASCENT system ahead of a US launch. In February 2026 it closed additional funding anchored by Embryo Ventures, appointed Christopher Campbell as US Commercial Lead to lead dedicated US operations, and added Dr. Nick Pachuda as a Non-Executive Director to support US market entry. Its near-term commercial focus is hospital and surgical centre adoption in the United States once regulatory clearance is secured.

Short descriptiontext

OSSTEC Ltd is a London-based orthopaedic device company spun out of Imperial College London that develops 3D-printed cementless partial knee implants using biomimetic fixation, selling to hospitals and orthopaedic surgeons and preparing for US market entry pending FDA clearance.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
3D printed implants, orthopedic devices, knee replacement, cementless fixation, medical implants
Industry4 codes
PRIMARYHLAHAEAA
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAEAJ
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYIMAAADAG
Medical & Dental 3D Printing Services (patient-specific devices, dental labs)
Industrials, Manufacturing & Construction/3D Printing/3D Printing Services (On-Demand Manufacturing & Service Bureaus)
SECONDARYHLAKALAH
Hip & Knee Reconstruction (Arthroplasty)
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Orthopedic Implants
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

OSSTEC generates revenue through the sale of 3D printed knee implants and joint replacement technology to healthcare providers and surgical centers

businesscloud.co.uk
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

OSSTEC develops and manufactures 3D-printed knee implants featuring biomimetic cementless fixation technology designed to stimulate bone growth and reduce implant failure. Its flagship ASCENT Cementless Partial Knee System combines 3D-printed articulating surfaces with cementless fixation to enable long-term biologic fixation without cement. The company leverages approximately 10 years of innovation originating at Imperial College London to address high implant loosening and revision rates in joint replacement surgery.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Cementless implants reduce the risk of loosening by 50%
+2 more records
Product overview1 text field

OSSTEC offers a focused portfolio of 3D-printed orthopedic implant products built on biomimetic cementless fixation technology. The primary offering is the ASCENT Cementless Partial Knee System, supplemented by 3D printed knee implants that combine innovative articulating surfaces with biomimetic cementless fixation for enhanced functionality and long-lasting bone foundation. The company leverages over 10 years of technological innovation from Imperial College London to improve patient outcomes in joint replacement surgery.

Product and service2 records
1ASCENT Cementless Partial Knee System
CategoryOrthopedic Knee Implants
Description

OSSTEC's flagship cementless partial knee replacement system designed for orthopedic surgeons and hospitals. It uses biomimetic 3D-printed fixation technology to stimulate bone growth and reduce implant failure risks in knee replacement procedures.

23D Printed Knee Implants
CategoryOrthopedic Knee Implants
Description

Knee implants combining 3D-printed articulating surfaces with biomimetic cementless fixation for orthopedic surgeons and hospitals. Designed to provide enhanced functionality, superior fixation, and a long-lasting bone foundation while reducing loosening risk.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

One of the largest orthopedic joint reconstruction players with cementless and partial knee offerings (e.g., Persona Partial). Directly comparable because it targets the same orthopedic surgeons and hospitals for cementless partial knee replacement, though as a broad multi-product incumbent rather than a focused 3D-printed specialist.

TypeBroad incumbent
Description

Global orthopedic giant with MAKO robotic knee platform and Triathlon cementless total/partial knee systems. Comparable as it competes in the same cementless knee replacement category with deep hospital sales coverage, but as a multi-product incumbent spanning trauma, joint recon, and robotics.

TypeBroad incumbent
Description

Orthopedic joint reconstruction leader with Journey II and Oxford Partial Knee cementless systems. Directly comparable in the partial knee / cementless fixation space, but operates across a much broader orthopedic, sports medicine, and wound care portfolio.

TypeDirect peer
Description

Patient-specific 3D-printed orthopedic implant company (formerly ConforMIS iTotal/iUni/iDuo). Most directly comparable peer because it uses 3D printing to manufacture cementless, patient-specific knee implants targeting the same hospital and surgeon customers as OSSTEC.

TypeEmerging player
Description

Swiss orthopedic company with cementless knee platforms (GMK Sphere, MyKnee) and a focus on surgeon training (M.O.R.E. Institute). Comparable as an emerging challenger to incumbents with cementless knee technology and a surgeon-training-led GTM similar to OSSTEC's approach.

TypeEmerging player
Description

UK-based orthopedic company with a hip and knee portfolio including the Unity Partial Knee. Comparable as a mid-sized orthopedic challenger with a focused joint reconstruction portfolio, though based in the UK with similar GTM constraints.

TypeEmerging player
Description

German specialist orthopedic manufacturer with partial knee (LINK Sled) and cementless systems. Comparable as an EMEA-based specialist focused on joint replacement, narrower in scale than Stryker/Zimmer but directly competitive in the partial knee space.

8Bodycad
TypeDirect peer
Description

Canadian patient-specific 3D-printed orthopedic implant company focused on personalized knee and hip reconstruction. Comparable as a small-scale competitor using 3D printing to produce custom orthopedic implants for joint replacement surgery.

TypeBroad incumbent
Description

Diversified orthopedic and medical technology company with knee and hip reconstruction products. Comparable as a competitor in the orthopedic implant market with sales infrastructure to hospitals and surgical centers, though broader in scope beyond knee.

TypeEmerging player
Description

Orthopedic joint reconstruction company offering the Evolution Medial-Pivot knee system. Comparable as a focused orthopedic challenger targeting knee replacement surgery with an emphasis on differentiation through implant design.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

OSSTEC

Orthopedic Implantsosstec.uk

OSSTEC Ltd is a London-based orthopaedic device company spun out of Imperial College London that develops 3D-printed cementless partial knee implants using biomimetic fixation, selling to hospitals and orthopaedic surgeons and preparing for US market entry pending FDA clearance.

What OSSTEC does

OSSTEC Ltd is a UK-based orthopaedic medical device company incorporated in England and Wales and headquartered at Imperial College London, London, from which it spun out. The company develops 3D-printed knee implants built on a biomimetic cementless fixation platform that the company claims reduces the risk of implant loosening by approximately 50% compared with cemented alternatives and addresses a 35% long-term failure rate in younger, more active patients. Its flagship offering, the ASCENT Cementless Partial Knee System, combines novel 3D-printed articulating surfaces with cementless biologic fixation derived from roughly a decade of research at Imperial College London.

OSSTEC generates revenue through hardware sales of its implants to hospitals and surgical centres via enterprise field sales and direct hospital distribution, with pricing negotiated through hospital procurement. The go-to-market is targeted at orthopaedic surgeons performing partial knee replacement, a procedure it estimates is appropriate for about 50% of knee replacement candidates based on its published content. The company is led by surgeons and engineers, including CTO & Co-Founder Jonathan Jeffers, Founder & CEO Maxwell Munford, and Chair Dominique Kleyn, with clinical endorsement from academic surgeons such as Mr. Alex Liddle (DPhil FRCS(Orth)).

The company remains at an early commercial stage: it employs 1-10 people, has raised a £2.5 million seed round in April 2025 alongside earlier seed capital, and is actively pursuing FDA regulatory clearance for the ASCENT system ahead of a US launch. In February 2026 it closed additional funding anchored by Embryo Ventures, appointed Christopher Campbell as US Commercial Lead to lead dedicated US operations, and added Dr. Nick Pachuda as a Non-Executive Director to support US market entry. Its near-term commercial focus is hospital and surgical centre adoption in the United States once regulatory clearance is secured.

OSSTEC firmographics

Firmographics
Name
OSSTEC
Legal name
OSSTEC Ltd
Website
https://osstec.uk
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
OSSTEC Ltd is a London-based orthopaedic device company spun out of Imperial College London that develops 3D-printed cementless partial knee implants using biomimetic fixation, selling to hospitals and orthopaedic surgeons and preparing for US market entry pending FDA clearance.
Ownership category
akta.pro rank

OSSTEC industry classification

Industry
Product category
Orthopedic Implants
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAEAA
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAEAJ
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYIMAAADAG
Medical & Dental 3D Printing Services (patient-specific devices, dental labs)
Industrials, Manufacturing & Construction/3D Printing/3D Printing Services (On-Demand Manufacturing & Service Bureaus)
SECONDARYHLAKALAH
Hip & Knee Reconstruction (Arthroplasty)

Keywords

  • 3D printed implants
  • Orthopedic devices
  • Knee replacement
  • Cementless fixation
  • Medical implants

Where OSSTEC is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

OSSTEC business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Medical Device Sales: OSSTEC generates revenue through the sale of 3D printed knee implants and joint replacement technology to healthcare providers and surgical centers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

OSSTEC product offering

Product offering

Core offering

OSSTEC develops and manufactures 3D-printed knee implants featuring biomimetic cementless fixation technology designed to stimulate bone growth and reduce implant failure. Its flagship ASCENT Cementless Partial Knee System combines 3D-printed articulating surfaces with cementless fixation to enable long-term biologic fixation without cement. The company leverages approximately 10 years of innovation originating at Imperial College London to address high implant loosening and revision rates in joint replacement surgery.

Product overview

OSSTEC offers a focused portfolio of 3D-printed orthopedic implant products built on biomimetic cementless fixation technology. The primary offering is the ASCENT Cementless Partial Knee System, supplemented by 3D printed knee implants that combine innovative articulating surfaces with biomimetic cementless fixation for enhanced functionality and long-lasting bone foundation. The company leverages over 10 years of technological innovation from Imperial College London to improve patient outcomes in joint replacement surgery.

Differentiator

Problem solved

Functional benefit

Products and services

  • ASCENT Cementless Partial Knee System OSSTEC's flagship cementless partial knee replacement system designed for orthopedic surgeons and hospitals. It uses biomimetic 3D-printed fixation technology to stimulate bone growth and reduce implant failure risks in knee replacement procedures.
  • 3D Printed Knee Implants Knee implants combining 3D-printed articulating surfaces with biomimetic cementless fixation for orthopedic surgeons and hospitals. Designed to provide enhanced functionality, superior fixation, and a long-lasting bone foundation while reducing loosening risk.

Quantifiable outcome

  • Cementless implants reduce the risk of loosening by 50%
  • +2 more outcomes

Companies that use OSSTEC

Customer profile

Segments2 records

Ideal customer profiles1 record

OSSTEC technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

OSSTEC partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

OSSTEC competitors and assessment

Company assessment

Broad incumbents

  • Zimmer Biomet: One of the largest orthopedic joint reconstruction players with cementless and partial knee offerings (e.g., Persona Partial). Directly comparable because it targets the same orthopedic surgeons and hospitals for cementless partial knee replacement, though as a broad multi-product incumbent rather than a focused 3D-printed specialist.
  • Stryker Corporation: Global orthopedic giant with MAKO robotic knee platform and Triathlon cementless total/partial knee systems. Comparable as it competes in the same cementless knee replacement category with deep hospital sales coverage, but as a multi-product incumbent spanning trauma, joint recon, and robotics.
  • Smith & Nephew: Orthopedic joint reconstruction leader with Journey II and Oxford Partial Knee cementless systems. Directly comparable in the partial knee / cementless fixation space, but operates across a much broader orthopedic, sports medicine, and wound care portfolio.
  • Enovis Corporation (DJO): Diversified orthopedic and medical technology company with knee and hip reconstruction products. Comparable as a competitor in the orthopedic implant market with sales infrastructure to hospitals and surgical centers, though broader in scope beyond knee.

Direct peers

  • restor3d: Patient-specific 3D-printed orthopedic implant company (formerly ConforMIS iTotal/iUni/iDuo). Most directly comparable peer because it uses 3D printing to manufacture cementless, patient-specific knee implants targeting the same hospital and surgeon customers as OSSTEC.
  • Bodycad: Canadian patient-specific 3D-printed orthopedic implant company focused on personalized knee and hip reconstruction. Comparable as a small-scale competitor using 3D printing to produce custom orthopedic implants for joint replacement surgery.

Emerging players

  • Medacta International: Swiss orthopedic company with cementless knee platforms (GMK Sphere, MyKnee) and a focus on surgeon training (M.O.R.E. Institute). Comparable as an emerging challenger to incumbents with cementless knee technology and a surgeon-training-led GTM similar to OSSTEC's approach.
  • Corin Group: UK-based orthopedic company with a hip and knee portfolio including the Unity Partial Knee. Comparable as a mid-sized orthopedic challenger with a focused joint reconstruction portfolio, though based in the UK with similar GTM constraints.
  • Waldemar Link: German specialist orthopedic manufacturer with partial knee (LINK Sled) and cementless systems. Comparable as an EMEA-based specialist focused on joint replacement, narrower in scale than Stryker/Zimmer but directly competitive in the partial knee space.
  • MicroPort Orthopedics: Orthopedic joint reconstruction company offering the Evolution Medial-Pivot knee system. Comparable as a focused orthopedic challenger targeting knee replacement surgery with an emphasis on differentiation through implant design.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

OSSTEC social profiles

Digital presence

OSSTEC financial estimates

Financial estimate

Revenue estimate

Valuation estimate

OSSTEC leadership team

Management profile

Number of profiles

Profiles5 records

OSSTEC funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

OSSTEC M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OSSTEC

What does OSSTEC do?

OSSTEC develops and manufactures 3D-printed knee implants featuring biomimetic cementless fixation technology designed to stimulate bone growth and reduce implant failure. Its flagship ASCENT Cementless Partial Knee System combines 3D-printed articulating surfaces with cementless fixation to enable long-term biologic fixation without cement. The company leverages approximately 10 years of innovation originating at Imperial College London to address high implant loosening and revision rates in joint replacement surgery.

Is OSSTEC a public or private company?

OSSTEC is a private company. It is classified as venture growth investor backed and is currently operating.

When was OSSTEC founded?

OSSTEC was founded in 2021. It employs 11 to 50 people.

Where is OSSTEC based?

OSSTEC is headquartered in London, United Kingdom, in the Europe region.

How does OSSTEC make money?

One revenue line is on record: medical Device Sales.

Who are OSSTEC's main competitors?

Broad incumbents on record are Zimmer Biomet, Stryker Corporation, Smith & Nephew and Enovis Corporation (DJO). Direct peers are restor3d and Bodycad. Emerging players are Medacta International, Corin Group, Waldemar Link and MicroPort Orthopedics.

Does OSSTEC have an API?

No public API is recorded for OSSTEC.

What industry is OSSTEC in?

OSSTEC's product category is Orthopedic Implants. Its primary akta.pro industry code is HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle), with a secondary code of HLAHAEAJ, 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
VoxelMattersOSSTEC raises $8 million to bring its 3D printed partial knee to the U.S.OSSTEC, a spinout from Imperial College London, closed an $8 million investment round to fund the U.S. launch of Ascent, its 3D printed cementless partial knee system. The funds will cover U.S. regulatory approval, surgeon training, and first surgical cases, with patients expected to receive the implant next year.TCT MagazineOSSTEC raises $8m to fund in-human surgical cases of 3D printing-enabled ASCENT knee implantOSSTEC raised $8 million led by EMBRYO Ventures to fund first-in-human US surgical cases of its ASCENT 3D-printed partial knee implant. The capital will support FDA clearance and surgeon training, with procedures planned for the first half of 2027. The company is expanding its cementless fixation platform beyond knee replacement.Medical BuyerOSSTEC closes USD 8M funding roundOSSTEC closed $8 million in funding led by EMBRYO Ventures to fund first-in-human US surgical cases of its ASCENT cementless partial knee system. The capital will support FDA clearance and training, with procedures planned for the first half of 2027. The company is expanding its pipeline of cementless applications beyond partial knee replacement.Mirage NewsImperial Startup OSSTEC Raises $8m for US LaunchOSSTEC, a startup from Imperial College London, raised $8 million to support its US launch of Ascent, a 3D-printed cementless partial knee system. The funding will cover regulatory approval and surgeon training, with the company targeting first US cases next year. It is also developing new cementless applications beyond the knee.Pulse 2.0OSSTEC Raises $8 Million To Advance ASCENT Cementless Partial Knee System Toward U.S. LaunchOSSTEC raised $8 million led by EMBRYO Ventures to advance its ASCENT cementless partial knee system toward U.S. launch. The funds will support FDA clearance and first-in-human procedures, expected in the first half of 2027. The company plans to train surgeon faculty and develop additional cementless joint applications.BitlyImperial startup OSSTEC raises $8m for US launch of innovative joint replacementsOSSTEC, an Imperial College London startup, raised $8 million to support its US launch of Ascent, a 3D-printed cementless partial knee system. The funding will cover regulatory approval and surgeon training, with the company planning new cementless applications and robotic surgery integration.Startup ResearcherOSSTEC Raises $8 Million for Cementless Partial KneeOSSTEC closed an $8 million funding round led by EMBRYO Ventures for its cementless partial knee system. The funds will support first-in-human U.S. surgical cases, with procedures planned for the first half of 2027. The company is also expanding its pipeline beyond partial knee replacement.openPR.comOrthopedic Medical Robots Market is projected to Hit US$ 11.3 Billion by 2033 | Emerging Companies - OSSTEC, Nivalon Medical, HAPPE Spine, Forma Medical, Shoulder InnovationsDataM Intelligence released a market research report on the Orthopedic Medical Robots Market, showing the global market reached US$10.7 billion in 2025 and is projected to grow to US$11.3 billion by 2033, with a CAGR of 10.9%. Recent M&A activity in the sector includes Maxx Orthopedics acquiring TracPatch to expand its robotics-linked recovery ecosystem and Smith & Nephew acquiring Integrity Orthopaedics for up to $450 million to strengthen its orthopedic division with robotics-enabled solutions.Business Wire BlogOSSTEC Appoints Dr. Nick Pachuda to Board and Establishes US Operations Ahead of US Market EntryOSSTEC, a UK-based orthopaedics company developing cementless knee replacement technology, has appointed Dr. Nick Pachuda to its Board of Directors and established dedicated US operations led by Christopher Campbell to support its market entry strategy. The company has also successfully closed additional funding anchored by venture capital firm Embryo Ventures, with participation from existing investors, to fund US operations scaling, commercial readiness, and surgeon training ahead of anticipated FDA clearance for its ASCENT cementless partial knee system. The expansion marks a pivotal stage in OSSTEC's strategy to enter the world's largest orthopaedic market, supported by an established US surgeon faculty network.MorningstarOSSTEC Appoints Dr. Nick Pachuda to Board and Establishes US Operations Ahead of US Market EntryOSSTEC, a UK-based orthopaedics company, has announced two strategic moves ahead of its US market entry: appointing Dr. Nick Pachuda as a Non-Executive Director and establishing dedicated US operations under Christopher Campbell as US Commercial Lead. The company has also closed additional funding anchored by Embryo Ventures, with participation from existing investors, to support US operations scaling, commercial readiness, and surgeon training ahead of regulatory clearance for its ASCENT cementless partial knee system.